ESTRO 2024 - Abstract Book

S299

Brachytherapy - Head & neck, skin, eye

ESTRO 2024

Tumour localization

Peripheral

21 (12%)

Midperipheral

62 (36%)

Central

89 (52%) 40 (23%)

Juxtapapillary location

(<1 disk diameter from optic disk)

Comorbidities ipsilateral eye at diagnosis

Glaucoma

10 (6%)

Retinal detachment

20 (12%)

Vitreous body hemorrhage

4 (2%)

Maculopathy

6 (4%)

Cataract grade I

59 (34%)

Cataract grade ≥II or previous cataract surgery

29 (17%)

Tumour apex dose(Gy)

130 (81-209)

Scleral dose(Gy)

375 (235-1433)

Table 1 Clinical characteristics of the cohort(n=172). Continuous variables: median(range).